It is a pharma private limited company based in Bangalore South, Karnataka, India, established in 2020.
2020 | Bangalore South, Karnataka, India | ActiveSkizze Pharmaceuticals Private Limited, a active private limited company, was established on 25 September 2020 in Bangalore South, Karnataka, India. Engaging in drug formulation & development within the hospital and medical care sector, it holds CIN: U24100KA2020PTC139025. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹2.04 Cr.
It upholds a compliant status. Its leadership includes Narayana Gowda Thanuja Prasad (Director), Sadananda Kumar Giliyaru (Additional Director), Kadegowda Somashekar (Director). Past directors included Boppana Srikanth, Shivanand Kumar Giliyaru. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at No. 15 Shop No. 3, Gavipuram Hbcs Layout, 60 Feet Kuvempu Road, Jnanabharathi 2Nd Stage Nagadevanahaali, Bangalore South, Karnataka, 560056.
U24100KA2020PTC139025
139025
25 September 2020
₹3.00 Cr
₹2.04 Cr
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Skizze Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Narayana Gowda Thanuja Prasad | Director | 25 Sep 2020 | Current |
| Sadananda Kumar Giliyaru | Additional Director | 09 Sep 2023 | Current |
| Kadegowda Somashekar | Director | 25 Sep 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 22 Nov 2021 | Past |
| Pramod Abcsdd | Additional Director | 09 Sep 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Skizze Pharmaceuticals Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2021, Skizze Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Skizze Pharmaceuticals has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Skizze Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Skizze Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Skizze Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Skizze Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was documented.
Progress on Sadananda Kumar Giliyaru was appointed as a Additional Director was appointed as a Additional Director on 09 Sep 2023 & has been associated with this company since 2 years 2 months . was documented.
Progress on Narayana Gowda Thanuja Prasad was appointed as a Director was appointed as a Director on 25 Sep 2020 & has been associated with this company since 5 years 2 months . was documented.
Progress on Kadegowda Somashekar was appointed as a Director was appointed as a Director on 25 Sep 2020 & has been associated with this company since 5 years 2 months . was documented.
Skizze Pharmaceuticals Private Limited was registered on 25 Sep 2020 with Roc Bangalore & aged 5 years 2 months as per MCA records. was recorded as a recent event.
The CIN of Skizze Pharmaceuticals Private Limited is U24100KA2020PTC139025.
Skizze Pharmaceuticals Private Limited is headquartered at No. 15 Shop No. 3, Gavipuram Hbcs Layout, 60 Feet Kuvempu Road, Jnanabharathi 2Nd Stage Nagadevanahaali, Bangalore South, Karnataka, 560056.
Skizze Pharmaceuticals Private Limited was incorporated on 25 September 2020.
The current directors of Skizze Pharmaceuticals Private Limited are
The primary industry of Skizze Pharmaceuticals Private Limited is Hospital And Medical Care.
Skizze Pharmaceuticals Private Limited is unlisted.
The authorized capital of Skizze Pharmaceuticals Private Limited is ₹3.00 Cr, and the paid-up capital is ₹2.04 Cr.
The compliance status of Skizze Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX